Karolinska Development AB (publ)

SSE:KDEV.ST

1.65 (SEK) • At close February 20, 2024
Bedrijfsnaam Karolinska Development AB (publ)
Symbool KDEV.ST
Munteenheid SEK
Prijs 1.65
Beurswaarde 441,008,230
Dividendpercentage 0%
52-weken bereik 1.41 - 2.05
Industrie Biotechnology
Sector Healthcare
CEO Mr. Johan Dighed
Website https://www.karolinskadevelopment.com

An error occurred while fetching data.

Over Karolinska Development AB (publ)

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The

Vergelijkbare Aandelen

Enzymatica AB (publ) logo

Enzymatica AB (publ)

ENZY.ST

3.05 SEK

Boule Diagnostics AB (publ) logo

Boule Diagnostics AB (publ)

BOUL.ST

9.36 SEK

Integrum AB (publ) logo

Integrum AB (publ)

INTEG-B.ST

43.35 SEK

Egetis Therapeutics AB (publ) logo

Egetis Therapeutics AB (publ)

EGTX.ST

6.07 SEK

Physitrack PLC logo

Physitrack PLC

PTRK.ST

15.2 SEK

Orexo AB (publ) logo

Orexo AB (publ)

ORX.ST

14.5 SEK

Episurf Medical AB (publ) logo

Episurf Medical AB (publ)

EPIS-B.ST

0.98 SEK

Stille AB logo

Stille AB

STIL.ST

160.5 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)